<DOC>
	<DOCNO>NCT00959842</DOCNO>
	<brief_summary>This study build upon previous finding show triglyceride lower effect prescription omega-3 combine therapy statin . The propose study use simple change baseline design 15 subject hypertriglyceridemic stable statin therapy . The protocol involve 3 study visit ; involve draw blood sample : day 1 - screening ( blood draw qualification safety ) ; day 7 - take prescription omega-3 fatty acid ( Lovaza , 4 capsules/d ; GlaxoSmithKline ) , day 63 -after take prescription omega-3 fatty acid ( Lovaza , 4 capsules/d ; GlaxoSmithKline ) . The propose study include 15 subject utilize several different measure lipoprotein structure function . The investigator measure functional parameter bind affinity lipoproteins treatment omega-3 fatty acid . The investigator also measure fatty acid , oxylipin apolipoprotein content plasma , very-low-density lipoprotein ( VLDL ) , low-density lipoprotein ( LDL ) high-density lipoprotein ( HDL ) .</brief_summary>
	<brief_title>Effects Lovaza Lipoprotein Composition Function Mild Hypertriglyceridemia</brief_title>
	<detailed_description>This study build upon previous finding show triglyceride lower effect prescription omega-3 combine therapy statin . The propose study use simple change baseline design 15 subject hypertriglyceridemic stable statin therapy . The protocol involve 3 study visit ; involve draw blood sample : day 1 - screening ( blood draw qualification safety ) ; day 7 - take prescription omega-3 fatty acid ( Lovaza , 4 capsules/d ; GlaxoSmithKline ) , day 63 -after take prescription omega-3 fatty acid ( Lovaza , 4 capsules/d ; GlaxoSmithKline ) . The propose study include 15 subject utilize several different measure lipoprotein structure function . The investigator measure functional parameter bind affinity lipoproteins treatment omega-3 fatty acid . The investigator also measure fatty acid , oxylipin apolipoprotein content plasma , very-low-density lipoprotein ( VLDL ) , low-density lipoprotein ( LDL ) high-density lipoprotein ( HDL ) .</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>1879 year Stable statin ≥ 8 week prior screen Good health medical history , physical exam , electrocardiogram , laboratory test ( e.g. , serum chem. , urinalysis ) Mean fast serum triglyceride two recent test medical record ≥ 200 &lt; 500 mg/dL Mean LDLcholesterol two recent test medical record ≤ 1.1 × NCEP ATP III goal Medications , vitamin pill , nutritional supplement herbal preparation deem exclusionary per primary investigator possible interference Poorly control diabetes mellitus ( e.g . [ HbA1c ] &gt; 8.0 % ) History cardiovascular event Past revascularization procedure Past aortic aneurysm aortic dissection &lt; 6 month prior screen History pancreatitis Sensitivity statin OR omega3 fatty acid fish product Poorly control hypertension ( i.e . : &gt; =160 systolic ( rest ) and/or &gt; =100 diastolic ( rest ) ) 2 consecutive visit Serum Creatinine ≥ 2.0 mg/dL Serum transaminase &gt; 1.5 × upper limit normal ( ULN ) ; include aspartate aminotransferase [ AST ] alanine aminotransferase [ ALT ] ; 31 U/L AST , 45 U/L ALT Creatine Kinase ( CK ) &gt; 3.0 × ULN Taking triglyceride lower drug ( e.g. , niacin , fibrates ) fish oil supplement provide 500 mg EPA+DHA per day Contraindications Lovaza per product insert Women pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>Lipoprotein</keyword>
	<keyword>Statin</keyword>
	<keyword>Lovaza</keyword>
</DOC>